AI assistant
Sending…
Hoth Therapeutics, Inc. — Director's Dealing 2022
Dec 13, 2022
34935_dirs_2022-12-13_4e41ecf2-cf58-4741-b4ef-0137ac43930f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2022-12-07
Reporting Person: Pavell Jeff (Director)
More from Hoth Therapeutics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 2